Assenagon Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.7M Buy
365,248
+119,619
+49% +$33.1M 0.1% 155
2026
Q1
$72.5M Buy
245,629
+235,067
+2,226% +$69.8M 0.11% 145
2025
Q4
$2.88M Sell
10,562
-603,321
-98% -$164M ﹤0.01% 774
2025
Q3
$166M Buy
613,883
+430,851
+235% +$117M 0.23% 88
2025
Q2
$50.4M Buy
183,032
+69,196
+61% +$18.8M 0.07% 207
2025
Q1
$30.2M Buy
113,836
+98,650
+650% +$24.3M 0.05% 280
2024
Q4
$3.53M Sell
15,186
-729,658
-98% -$168M 0.01% 780
2024
Q3
$164M Buy
744,844
+99,514
+15% +$20.6M 0.3% 57
2024
Q2
$127M Buy
645,330
+550,133
+578% +$114M 0.28% 70
2024
Q1
$20.5M Buy
95,197
+85,870
+921% +$18M 0.05% 275
2023
Q4
$1.96M Sell
9,327
-437,871
-98% -$93.4M 0.01% 938
2023
Q3
$89.5M Buy
447,198
+79,886
+22% +$15.9M 0.28% 57
2023
Q2
$68.1M Buy
367,312
+181,118
+97% +$33.5M 0.24% 80
2023
Q1
$35.7M Buy
186,194
+177,021
+1,930% +$32M 0.13% 150
2022
Q4
$1.54M Sell
9,173
-156,431
-94% -$27.2M 0.01% 915
2022
Q3
$29.3M Buy
165,604
+78,803
+91% +$15.6M 0.11% 178
2022
Q2
$17.8M Sell
86,801
-46,299
-35% -$9.81M 0.07% 248
2022
Q1
$31.7M Buy
133,100
+128,090
+2,557% +$30.1M 0.09% 190
2021
Q4
$1.15M Sell
5,010
-32,807
-87% -$7.22M ﹤0.01% 987
2021
Q3
$7.31M Buy
37,817
+35,002
+1,243% +$7.09M 0.02% 336
2021
Q2
$599K Buy
+2,815
New +$594K ﹤0.01% 1012
2020
Q4
Sell
-15,374
Closed -$2.57M 1049
2020
Q3
$2.57M Sell
15,374
-25,500
-62% -$4.3M 0.01% 529
2020
Q2
$6.64M Sell
40,874
-48,351
-54% -$8.67M 0.04% 266
2020
Q1
$15.4M Buy
89,225
+79,415
+810% +$15.8M 0.12% 129
2019
Q4
$1.97M Sell
9,810
-6,130
-38% -$1.26M 0.01% 449
2019
Q3
$3.37M Sell
15,940
-265,670
-94% -$55.5M 0.02% 303
2019
Q2
$54.7M Buy
281,610
+256,093
+1,004% +$47.2M 0.41% 52
2019
Q1
$4.2M Buy
25,517
+259
+1% +$45.8K 0.04% 346
2018
Q4
$4.75M Buy
25,258
+8,937
+55% +$1.65M 0.05% 247
2018
Q3
$2.78M Sell
16,321
-2,813
-15% -$474K 0.03% 442
2018
Q2
$3.14M Sell
19,134
-8,798
-31% -$1.44M 0.04% 267
2018
Q1
$4.52M Buy
27,932
+15,435
+124% +$2.46M 0.06% 245
2017
Q4
$1.82M Sell
12,497
-62,702
-83% -$8.93M 0.02% 451
2017
Q3
$10.2M Buy
75,199
+43,055
+134% +$5.44M 0.09% 173
2017
Q2
$4.03M Sell
32,144
-531
-2% -$63.5K 0.09% 94
2017
Q1
$3.88M Buy
32,675
+6,311
+24% +$759K 0.08% 107
2016
Q4
$3.04M Buy
+26,364
New +$2.93M 0.06% 142

Other funds holding CME

Assenagon Asset Management's CME Position: Q2 2026 in Review

Assenagon Asset Management increased its CME Group (CME) stake by 49% in Q2 2026, buying an estimated $33.1M and bringing the position to 365,248 shares worth $80.7M. The position accounts for 0.1% of the portfolio, ranked #155.

Assenagon Asset Management first reported a position in CME in Q4 2016 and has held it in 37 quarters since. The position peaked at $166M in Q3 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Assenagon Asset Management held 365,248 shares of CME Group worth $80.7M as of Q2 2026.
  • Assenagon Asset Management bought 119,619 CME Group shares in Q2 2026, an estimated $33.1M.
  • CME Group made up 0.1% of Assenagon Asset Management's portfolio in Q2 2026, its #155 holding.
  • Assenagon Asset Management first reported a position in CME Group in Q4 2016 and has held it in 37 quarters since.
  • Assenagon Asset Management's CME Group position peaked at $166M in Q3 2025.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.